Travere Therapeutics (TVTX) Prepaid Assets (2013 - 2026)

Travere Therapeutics (TVTX) posted Prepaid Assets of $34.3 million for Q1 2026, up 19.43% on a QoQ basis from $28.8 million in Q4 2025, and up 152.25% year-over-year from $13.6 million in Q1 2025.

Travere Therapeutics (TVTX) Prepaid Assets (2013 - 2026) Analysis & Trends

Travere Therapeutics' Prepaid Assets history runs 14 years deep, the most recent figure standing at $34.3 million for Q1 2026.

  • Quarterly Prepaid Assets rose 152.25% year-over-year to $34.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $34.3 million (up 152.25% YoY) and the FY2025 annual result came in at $28.8 million, up 126.72% from the prior year.
  • Prepaid Assets was $34.3 million for Q1 2026 at Travere Therapeutics, up from $28.8 million in the prior quarter.
  • Across five years, Prepaid Assets topped out at $34.3 million in Q1 2026 and bottomed at $6.5 million in Q1 2022.
  • A 5-year average of $16.2 million and a median of $13.6 million in 2025 frame the typical range for Prepaid Assets.
  • Annual changes were most pronounced in 2024 — Prepaid Assets sank 34.39% — and 2026, when it jumped 152.25%.
  • Travere Therapeutics' Prepaid Assets stood at $12.0 million in 2022, then soared by 60.68% to $19.3 million in 2023, then sank by 34.39% to $12.7 million in 2024, then surged by 126.72% to $28.8 million in 2025, then increased by 19.43% to $34.3 million in 2026.
  • Business Quant data shows TVTX's Prepaid Assets at $34.3 million in Q1 2026, $28.8 million in Q4 2025, and $28.0 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 Travere Therapeutics 5.21 Bn 5.21 Bn 125.25 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 34.35 Mn
Dec 31, 2025 28.76 Mn
Sep 30, 2025 28.05 Mn
Jun 30, 2025 17.22 Mn
Mar 31, 2025 13.62 Mn
Dec 31, 2024 12.69 Mn
Sep 30, 2024 15.78 Mn
Jun 30, 2024 13.14 Mn
Mar 31, 2024 12.77 Mn
Dec 31, 2023 19.34 Mn
Sep 30, 2023 16.24 Mn
Jun 30, 2023 11.56 Mn
Mar 31, 2023 15.14 Mn
Dec 31, 2022 12.03 Mn
Sep 30, 2022 8.55 Mn
Jun 30, 2022 9.28 Mn
Mar 31, 2022 6.51 Mn
Dec 31, 2021 6.72 Mn
Sep 30, 2021 7.50 Mn
Jun 30, 2021 7.34 Mn